Skip to content

Lymph Node Ratio as a Predictor for Outcome in Rectal Cancer

Lymph Node Ratio as a Predictor for Outcome in Rectal Cancer: a Retrospective Cohort

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05221684
Enrollment
300
Registered
2022-02-03
Start date
2020-06-09
Completion date
2022-12-31
Last updated
2022-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrence

Brief summary

This study aims to evaluate the value of the LNR as a prognostic indicator in patients with rectal cancer who offered total mesorectal excision.

Detailed description

Patients and methods Study design and setting This is a retrospective review of prospectively collected and maintained database of patients with CRC admitted in the Oncology Center of Mansoura University (OCMU), the Colorectal Surgery Unit of Mansoura University Hospitals, and the Department of General Surgery of Alexandria University. Selection criteria Patients of either gender aged 18 years or above who presented with rectal cancer of any stage will be included in the study. We will exclude patients with patients younger than 18 years; patients with synchronous colon cancer; synchronous liver, pulmonary or bones metastasis; or synchronous gastrointestinal cancer; or patients who were lost to follow-up. Study endpoints The primary endpoint of the study is to assess the value of lymph node ratio (LNR) on the oncological outcomes.

Interventions

PROCEDURELymph node harvesting

Lymph node harvesting after radical resection for rectal cancer with curative intent

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* rectal cancer of TNM stage I-III * underwent radical resection with curative intent

Exclusion criteria

* synchronous colon cancer * synchronous gastrointestinal cancer * underwent palliative resection * presented with intestinal obstruction * those lost to follow-up.

Design outcomes

Primary

MeasureTime frameDescription
Lymph node valueone yearValue in prediction of oncological outcomes

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026